{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:53:55Z","timestamp":1790182435004,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"\n Importance<\/jats:title>\n Quality metrics with financial incentives are widely used, but their impact on clinical care and patient health remains challenging to isolate.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the association of a physician-facing quality metric and financial incentive for hypertension control (blood pressure &amp;lt;140\/90 mm Hg) with clinical decisions and health outcomes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This quasi-experimental difference-in-differences study in a large US health system compared changes in outcomes at practices that did vs those that did not adopt the financial incentive before (2021) vs after (2022-2023) adoption. Participants included patients with previously diagnosed hypertension, aged 18 to 85 years, with encounters at eligible primary care practices. Data were analyzed from January 2024 to September 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Patient exposure to the financial incentive was determined by which practice delivered their care.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Initial and final systolic blood pressure at the primary care encounter and number of measurements, antihypertensive prescriptions and dose adjustments, and hospitalizations for incident stroke or acute coronary syndrome (ACS).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study included 334\u202f364 patients with hypertension (mean [SD] age, 64.9 [12.6] years; 53.3% female) and their 770\u202f907 encounters at 103 primary care practices. In January 2022, the hypertension control financial incentive was introduced in physician contracts for 63 of these practices. In the overall population of patients with hypertension, the financial incentive was associated with an increased probability of blood pressure remeasurement (by 1.9 [95% CI, 0.7-3.1] percentage points [pp];\n P<\/jats:italic>\n \u2009=\u2009.002) with no statistically significant change in hypertension control, medication outcomes, or cardiovascular hospitalizations. For the subgroup of patients with marginally high blood pressure (defined as initial systolic blood pressure of 140-145 mm Hg), the financial incentive was associated with an increased probability (by 4.1 [95% CI, 2.1-6.0] pp;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) that blood pressure was documented as controlled, subsequent to an increased probability of blood pressure remeasurement (by 5.6 [95% CI, 2.9-8.3] pp;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The probability of an existing antihypertensive medication dose being increased was reduced (\u22121.1 [95% CI, \u22122.0 to \u22123.0] pp;\n P<\/jats:italic>\n \u2009=\u2009.01), and the 3-month risk of hospitalization for stroke or ACS increased (by 0.25 [95% CI, 0.07-0.44] pp;\n P<\/jats:italic>\n \u2009=\u2009.005), with excess risk growing to 0.52 pp (95% CI, 0.17-0.87 pp;\n P<\/jats:italic>\n \u2009=\u2009.008) pp at 1 year.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study\u2019s findings suggest that the addition a quality metric and financial incentive to physicians\u2019 contracts in a large health system had little impact on measured outcomes in the overall population of patients with hypertension. For patients with marginally high blood pressure, the incentive was associated with increased documented hypertension control because of selective remeasurement of blood pressure, decreased medication adjustments, and increased cardiovascular hospitalizations.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.1637","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:30:38Z","timestamp":1780327838000},"page":"965","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Consequences of a Hypertension Management Incentive"],"prefix":"10.1001","volume":"186","author":[{"given":"Claire","family":"Boone","sequence":"first","affiliation":[{"name":"Department of Economics and Department of Equity, Ethics, and Policy, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Robicsek","sequence":"additional","affiliation":[{"name":"Health Research Accelerator, Providence Innovation Institute, Portland, Oregon"},{"name":"Arclight Intelligence, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"ioi260026r1","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1001\/jama.2022.20619","article-title":"Association between individual primary care physician merit-based incentive payment system score and measures of process and patient outcomes.","volume":"328","author":"Bond","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"ioi260026r2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/1468-0009.12312","article-title":"Transformation of the health care industry: curb your enthusiasm?","volume":"96","author":"Burns","year":"2018","journal-title":"Milbank Q"},{"issue":"12","key":"ioi260026r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.38596","article-title":"Association between implementation of the severe sepsis and septic shock early management bundle performance measure and outcomes in patients with suspected sepsis in US hospitals.","volume":"4","author":"Rhee","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"ioi260026r4","first-page":"1","article-title":"Problems of monetary management: the U.K. experience.","volume":"1","author":"Goodhart","year":"1975","journal-title":"Pap Monet Econ"},{"issue":"21","key":"ioi260026r5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.2022.20945","article-title":"Pay for performance: when slogans overtake science in health policy.","volume":"328","author":"McWilliams","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"ioi260026r6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/1475-6773.12517","article-title":"Impact of a pay-for-performance program on care for Black patients with hypertension: important answers in the era of the Affordable Care Act.","volume":"52","author":"Petersen","year":"2017","journal-title":"Health Serv Res"},{"issue":"20","key":"ioi260026r7","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMhpr1316051","article-title":"Successes and failures of pay for performance in the United Kingdom.","volume":"370","author":"Roland","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi260026r8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7249\/rhq-04-03-09","article-title":"Measuring success in health care value-based purchasing programs: findings from an environmental scan, literature review, and expert panel discussions.","volume":"4","author":"Damberg","year":"2014","journal-title":"Rand Health Q"},{"issue":"5","key":"ioi260026r9","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association.","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"issue":"19","key":"ioi260026r10","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ioi260026r11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/IJGM.S164903","article-title":"Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice.","volume":"11","author":"Chadachan","year":"2018","journal-title":"Int J Gen Med"},{"issue":"6","key":"ioi260026r12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.113.01275","article-title":"White-coat hypertension: new insights from recent studies.","volume":"62","author":"Franklin","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"ioi260026r13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/HJH.0000000000001197","article-title":"Sources of inaccuracy in the measurement of adult patients\u2019 resting blood pressure in clinical settings: a systematic review.","volume":"35","author":"Kallioinen","year":"2017","journal-title":"J Hypertens"},{"issue":"11","key":"ioi260026r14","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation"},{"issue":"3","key":"ioi260026r15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1803180","article-title":"Effect of systolic and diastolic blood pressure on cardiovascular outcomes.","volume":"381","author":"Flint","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi260026r16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","article-title":"Blood pressure and the new ACC\/AHA hypertension guidelines.","volume":"30","author":"Flack","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"ioi260026r17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/pan.2016.2","article-title":"Generalized synthetic control method: causal inference with interactive fixed effects models.","volume":"25","author":"Xu","year":"2017","journal-title":"Polit Anal"},{"key":"ioi260026r18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev-economics-051520-021409","article-title":"Regression discontinuity designs.","volume":"14","author":"Cattaneo","year":"2022","journal-title":"Annu Rev Econ"},{"issue":"5","key":"ioi260026r19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/HYPERTENSIONAHA.121.14519","article-title":"Circadian rhythm, clock genes, and hypertension: recent advances in hypertension.","volume":"78","author":"Costello","year":"2021","journal-title":"Hypertension"},{"issue":"7","key":"ioi260026r20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jch.13304","article-title":"Blood pressure variability: clinical relevance and application.","volume":"20","author":"Parati","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"ioi260026r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.5231","article-title":"Association of economic policies with hypertension management and control: a systematic review.","volume":"5","author":"Zhang","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"10","key":"ioi260026r22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jama.2013.277353","article-title":"Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial.","volume":"310","author":"Bardach","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"ioi260026r23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2021.1565","article-title":"Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on initiating and intensifying medications: a prespecified secondary analysis of a randomized clinical trial.","volume":"6","author":"Peterson","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"10","key":"ioi260026r24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1001\/jama.2013.276303","article-title":"Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.","volume":"310","author":"Petersen","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"ioi260026r25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.amepre.2018.07.025","article-title":"Impact of financial incentives on service use, spending, and health in Medicaid.","volume":"55","author":"Romaire","year":"2018","journal-title":"Am J Prev Med"},{"key":"ioi260026r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/REST.a.1686","article-title":"Discretion in clinical decision making: evidence from bunching.","author":"Boone","year":"2025","journal-title":"Rev Econ Stat"},{"issue":"16","key":"ioi260026r27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2020.1816","article-title":"Quality measure development and associated spending by the Centers for Medicare & Medicaid Services.","volume":"323","author":"Wadhera","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"ioi260026r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.3105","article-title":"Changes in patient experiences and assessment of gaming among large clinician practices in precursors of the Merit-Based Incentive Payment System.","volume":"2","author":"Roberts","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"4","key":"ioi260026r29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/M17-3103","article-title":"The ACC\/AHA 2017 hypertension guidelines: both too much and not enough of a good thing?","volume":"168","author":"Cohen","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"ioi260026r30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jama.2017.19672","article-title":"Diagnosis and treatment of hypertension in the 2017 ACC\/AHA guidelines and in the real world.","volume":"319","author":"Ioannidis","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"ioi260026r31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tcm.2019.08.001","article-title":"Editorial commentary: Quo Vadis? On the diagnosis, management, treatment and control of arterial hypertension.","volume":"30","author":"Wyss","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"ioi260026r32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/01.HYP.0000093382.69464.C4","article-title":"Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values?","volume":"42","author":"Kannel","year":"2003","journal-title":"Hypertension"},{"issue":"8","key":"ioi260026r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.2020","article-title":"Value-based contracting in clinical care.","volume":"5","author":"Boone","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"3","key":"ioi260026r34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1377\/hlthaff.2015.1258","article-title":"US physician practices spend more than $15.4 billion annually to report quality measures.","volume":"35","author":"Casalino","year":"2016","journal-title":"Health Aff (Millwood)"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2849747\/jamainternal_boone_2026_oi_260026_1785440897.05795.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:00:40Z","timestamp":1785769240000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2849747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.1637","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}